Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Divestments: 2021-2023

  • Lifecore Biomedical's Divestments fell 96.46% to $1.0 million in Q2 2023 from the same period last year, while for May 2023 it was $45.1 million, marking a year-over-year change of. This contributed to the annual value of $16.7 million for FY2023, which is 77.32% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Divestments of $1.0 million as of Q2 2023, which was down 91.98% from $12.5 million recorded in Q1 2023.
  • Lifecore Biomedical's Divestments' 5-year high stood at $45.1 million during Q3 2021, with a 5-year trough of $1.0 million in Q2 2023.
  • Its 3-year average for Divestments is $18.0 million, with a median of $12.5 million in 2023.
  • Data for Lifecore Biomedical's Divestments shows a maximum YoY crashed of 96.46% (in 2023) over the last 5 years.
  • Lifecore Biomedical's Divestments (Quarterly) stood at $45.1 million in 2021, then plummeted by 93.05% to $3.1 million in 2022, then slumped by 96.46% to $1.0 million in 2023.
  • Its Divestments was $1.0 million in Q2 2023, compared to $12.5 million in Q1 2023 and $3.1 million in Q3 2022.